GBA1 and Parkinson disease: Midbrain dopaminergic neurons derived from induced pluripotent stem cells (iPSCs) of patients with PD carrying a heterozygous GBA1 variant (p.L483P or p.N409S) exhibited decreased GCase activity alongside increased levels of GlcCer and alpha-synuclein [124].